Procurement Summary
Country : USA
Summary : Neutrophil antibody testing and various blood products for the Department of Transfusion Medicine
Deadline : 21 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117610305
Document Ref. No. : 25-005571
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Title
Neutrophil antibody testing and various blood products for the Department of Transfusion Medicine
Product Service Code: 6506 NAICS Code: 621991 Place of Performance:Bethesda, MD 20892 USA
POTS: 25-005571
Description
This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested.
The National Institutes of Health (NIH) intends to award an indefinite delivery/indefinite quantity (IDIQ) task order on a sole source basis to The American National Red Cross, located in Washington, DC 20006-5310. The scope of the award includes the provision of neutrophil antibody testing and various blood products. The anticipated period of performance is from May 1, 2025, through April 30, 2026.
The National Institutes of Health (NIH) Department of Transfusion Medicine provides specialized care for numerous patients with sickle cell disease. One of the significant challenges in managing these patients is ensuring access to appropriately matched blood for transfusion. Individuals with sickle cell disease often have unique red cell phenotypes and require multiple red cell transfusions that are phenotype-matched to avoid alloimmunization and other complications.
During red cell exchange procedures—which typically require more than five units of blood—close coordination between the donor recruitment team and the blood donor center is essential. When suitable donors are not available within our facility, we often rely on external blood center distributors. Frequently, multiple blood centers must be engaged to source the required number of rare phenotype-matched red cell units, as no single facility may have an adequate supply.
This same challenge applies to patients with Severe Aplastic Anemia or those undergoing post-transplant treatment, where platelet support is critical. These patients often require HLA-matched platelet produ...
Active Contract Opportunity
Notice ID : 25-005571
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH - CC
General Information
Contract Opportunity Type: Presolicitation (Original)
Original Published Date: Apr 11, 2025 08:40 am EDT
Original Response Date: Apr 21, 2025 06:30 am EDT
Inactive Policy: Manual
Original Inactive Date: Apr 22, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6506 - BLOOD AND BLOOD PRODUCTS
NAICS Code: 621991 - Blood and Organ Banks
Place of Performance: Bethesda, MD 20892 USA
Documents
Tender Notice